chlorprothixene has been researched along with Cardiovascular Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Andersen, K; Fink-Jensen, A; Hallas, J; Højlund, M; Wagner, CB; Wesselhoeft, R | 1 |
GUALANDI, W | 1 |
Pieschl, D | 1 |
1 review(s) available for chlorprothixene and Cardiovascular Diseases
Article | Year |
---|---|
[The cardiovascular effects of neuroleptics based on current knowledge].
Topics: Adolescent; Adult; Aged; Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Blood Pressure; Cardiovascular Diseases; Chlorpromazine; Chlorprothixene; Death, Sudden; Dogs; Electrocardiography; Female; Heart; Humans; Male; Mesoridazine; Middle Aged; Phenothiazines; Schizophrenia; Tranquilizing Agents | 1973 |
2 other study(ies) available for chlorprothixene and Cardiovascular Diseases
Article | Year |
---|---|
Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study.
Topics: Cardiovascular Diseases; Chlorprothixene; Cohort Studies; Diabetes Mellitus, Type 2; Humans; Myocardial Infarction; Quetiapine Fumarate; Risk Factors | 2022 |
[NEUROLEPTANALGESIA IN SO-CALLED "POOR-RISK" PATIENTS].
Topics: Anesthesia; Arthroplasty; Ascites; Cardiovascular Diseases; Chlorprothixene; Dextromoramide; Esophageal Achalasia; Hip; Humans; Hypertension; Hypertension, Portal; Liver Cirrhosis; Neuroleptanalgesia; Succinylcholine; Surgical Procedures, Operative; Tranquilizing Agents | 1964 |